Bone Marrow Browser
Bone Marrow Browser
Home
De Jong 2021
De Jong 2024
Kellermayer 2024
Korst and Tahri 2025
Fokkema and Bertamini 2025
Links
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load
Under review 2025
Collaborative effort from
Myeloma Research Rotterdam
and
Myeloma lab Amsterdam UMC
Bone marrow NK cells:
NDMM vs. Control
Bone marrow NK cells:
NDMM CD38-positive NK cells
Bone marrow NK cells:
NDMM CD38-negative NK cells
Download CellRanger files for offline analysis